283 related articles for article (PubMed ID: 10954027)
21. Polymorphic variants of the beta2-adrenergic receptor (ADRB2) gene and ADRB2-related propanolol-induced dyslipidemia in the Colombian population.
Isaza C; Henao J; Ramirez E; Cuesta F; Cacabelos R
Methods Find Exp Clin Pharmacol; 2005 May; 27(4):237-44. PubMed ID: 16082424
[TBL] [Abstract][Full Text] [Related]
22. C825T polymorphism of the G protein beta3 subunit is associated with obesity but not with insulin sensitivity.
Stefan N; Stumvoll M; Machicao F; Koch M; Häring HU; Fritsche A
Obes Res; 2004 Apr; 12(4):679-83. PubMed ID: 15090636
[TBL] [Abstract][Full Text] [Related]
23. Postprandial plasma lipid levels are influenced by the interaction of functional polymorphisms in the microsome triglyceride transfer protein and beta3 adrenergic receptor genes.
Ueno T; Takahashi Y; Matsumoto T; Tsunemi A; Watanabe H; Tahira K; Fukuda N; Soma M; Matsumoto K
Med Sci Monit; 2007 May; 13(5):BR112-8. PubMed ID: 17476189
[TBL] [Abstract][Full Text] [Related]
24. High plasma norepinephrine levels associated with beta2-adrenoceptor polymorphisms predict future renal damage in nonobese normotensive individuals.
Masuo K; Katsuya T; Sugimoto K; Kawaguchi H; Rakugi H; Ogihara T; Tuck ML
Hypertens Res; 2007 Jun; 30(6):503-11. PubMed ID: 17664853
[TBL] [Abstract][Full Text] [Related]
25. Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function.
Large V; Hellström L; Reynisdottir S; Lönnqvist F; Eriksson P; Lannfelt L; Arner P
J Clin Invest; 1997 Dec; 100(12):3005-13. PubMed ID: 9399946
[TBL] [Abstract][Full Text] [Related]
26. Impact of genetic polymorphisms of the beta2-adrenergic receptor on albuterol bronchodilator pharmacodynamics.
Lima JJ; Thomason DB; Mohamed MH; Eberle LV; Self TH; Johnson JA
Clin Pharmacol Ther; 1999 May; 65(5):519-25. PubMed ID: 10340917
[TBL] [Abstract][Full Text] [Related]
27. Epistatic interaction between beta2-adrenergic receptor and neuropeptide Y genes influences LDL-cholesterol in hypertension.
Tomaszewski M; Charchar FJ; Lacka B; Pesonen U; Wang WY; Zukowska-Szczechowska E; Grzeszczak W; Dominiczak AF
Hypertension; 2004 Nov; 44(5):689-94. PubMed ID: 15364898
[TBL] [Abstract][Full Text] [Related]
28. Risk factors and myocardial infarction in patients with obstructive sleep apnea: impact of beta2-adrenergic receptor polymorphisms.
Bartels NK; Börgel J; Wieczorek S; Büchner N; Hanefeld C; Bulut D; Mügge A; Rump LC; Sanner BM; Epplen JT
BMC Med; 2007 Jan; 5():1. PubMed ID: 17198546
[TBL] [Abstract][Full Text] [Related]
29. [Effect of lipoprotein lipase gene polymorphism on plasma lipid levels,BMI and subcutaneous fat distribution in simple obesity children].
Guo X; Chen R; Mo B; Liu Q
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Apr; 17(2):105-7. PubMed ID: 10751532
[TBL] [Abstract][Full Text] [Related]
30. A mutation of the beta 3-adrenergic receptor is associated with visceral obesity but decreased serum triglyceride.
Kim-Motoyama H; Yasuda K; Yamaguchi T; Yamada N; Katakura T; Shuldiner AR; Akanuma Y; Ohashi Y; Yazaki Y; Kadowaki T
Diabetologia; 1997 Apr; 40(4):469-72. PubMed ID: 9112025
[TBL] [Abstract][Full Text] [Related]
31. Significance of beta2-adrenergic receptor gene polymorphism in obesity and type 2 diabetes mellitus in Korean subjects.
Kim SH; Kim DJ; Seo IA; Min YK; Lee MS; Kim KW; Lee MK
Metabolism; 2002 Jul; 51(7):833-7. PubMed ID: 12077726
[TBL] [Abstract][Full Text] [Related]
32. Polymorphism of the beta 3-adrenergic receptor gene in morbid obesity.
Oksanen L; Mustajoki P; Kaprio J; Kainulainen K; Jänne O; Peltonen L; Kontula K
Int J Obes Relat Metab Disord; 1996 Dec; 20(12):1055-61. PubMed ID: 8968849
[TBL] [Abstract][Full Text] [Related]
33. The glutamine 27 glutamic acid polymorphism of the beta2-adrenoceptor gene is associated with abdominal obesity and greater risk of impaired glucose tolerance in men but not in women: a population-based study in Spain.
González Sánchez JL; Proenza AM; Martínez Larrad MT; Ramis JM; Fernández Pérez C; Palou A; Serrano Ríos M
Clin Endocrinol (Oxf); 2003 Oct; 59(4):476-81. PubMed ID: 14510910
[TBL] [Abstract][Full Text] [Related]
34. Genetic variants of the human obesity (OB) gene: association with body mass index in young women, psychiatric symptoms, and interaction with the dopamine D2 receptor (DRD2) gene.
Comings DE; Gade R; MacMurray JP; Muhleman D; Peters WR
Mol Psychiatry; 1996 Sep; 1(4):325-35. PubMed ID: 9118359
[TBL] [Abstract][Full Text] [Related]
35. The Trp64Arg mutation of the beta3 adrenergic receptor gene has no effect on obesity phenotypes in the Québec Family Study and Swedish Obese Subjects cohorts.
Gagnon J; Mauriège P; Roy S; Sjöström D; Chagnon YC; Dionne FT; Oppert JM; Pérusse L; Sjöström L; Bouchard C
J Clin Invest; 1996 Nov; 98(9):2086-93. PubMed ID: 8903328
[TBL] [Abstract][Full Text] [Related]
36. A missense mutation in the human melanocortin-4 receptor gene in relation to abdominal obesity and salivary cortisol.
Rosmond R; Chagnon M; Bouchard C; Björntorp P
Diabetologia; 2001 Oct; 44(10):1335-8. PubMed ID: 11692184
[TBL] [Abstract][Full Text] [Related]
37. Beta2 adrenoceptor functional gene variants, obesity, and blood pressure level interactions in the general population.
Pereira AC; Floriano MS; Mota GF; Cunha RS; Herkenhoff FL; Mill JG; Krieger JE
Hypertension; 2003 Oct; 42(4):685-92. PubMed ID: 12900437
[TBL] [Abstract][Full Text] [Related]
38. Trp64Arg polymorphism of the beta 3-adrenergic receptor gene is associated with increased plasma leptin levels in obese Chinese women.
Lin SY; Sheu WH; Lee WJ; Song YM; Chen YT
Zhonghua Yi Xue Za Zhi (Taipei); 1999 Sep; 62(9):569-76. PubMed ID: 10502846
[TBL] [Abstract][Full Text] [Related]
39. Association of adrenergic receptor gene polymorphisms with adolescent obesity in Taiwan.
Chou YC; Tsai CN; Lee YS; Pei JS
Pediatr Int; 2012 Feb; 54(1):111-6. PubMed ID: 22115535
[TBL] [Abstract][Full Text] [Related]
40. An analysis of the link between polymorphisms of the beta2 and beta3 adrenergic receptor gene and metabolic parameters among Polish Caucasians with familial obesity.
Malczewska-Malec M; Wybrańska I; Leszczyńska-Gołabek I; Niedbał S; Kwaśniak M; Hartwich J; Kieć-Wilk B; Motyka M; Szopa M; Dembińska-Kieć A
Med Sci Monit; 2003 Jun; 9(6):CR225-34. PubMed ID: 12824951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
